Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Person › Details

Gabriele Elbl (MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR))

Elbl, Gabriele (MorphoSys 201312– Head of Regulatory Affairs before Wilex + EMA + Sanofi Winthrop)

 

Organisations Organisation MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX; Nasdaq: MOR)
  Group MorphoSys (Group)
  Former/major organisation Wilex AG
  Today Heidelberg Pharma AG (FSE: HPHA)
  Group Heidelberg Pharma (Group)
Products Product drug development
  Product 2 therapeutic antibody
     

   
Record changed: 2017-04-09

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px



To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x300px




» top